真の血圧を継続的に測定する初の非侵襲的方法を開発(Caltech Team Develops First Noninvasive Method to Continually Measure True Blood Pressure)

ad

2024-08-07 カリフォルニア工科大学(Caltech)

カリフォルニア工科大学(Caltech)の研究チームは、新しい特許技術「レゾナンスソノマノメトリー」を開発し、体のどこでも非侵襲的かつ連続的に血圧を測定する方法を発見しました。この技術は音波を用いて動脈の共鳴を刺激し、超音波でその共鳴周波数を測定して血圧を算出します。小規模な臨床試験では、従来の血圧計と同等の結果が得られました。このデバイスは病院、自宅、遠隔地でのバイタルサインのモニタリングに有望です。研究成果はPNAS Nexus誌に掲載されました。

<関連情報>

非侵襲的連続血圧モニタリングのための共鳴ソノマトメトリー Resonance sonomanometry for noninvasive, continuous monitoring of blood pressure

Raymond Jimenez, Dominic Yurk, Steven Dell, Austin C Rutledge, Matt K Fu, William P Dempsey, Yaser Abu-Mostafa, Aditya Rajagopal, Alaina Brinley Rajagopal
PNAS Nexus  Published:30 July 2024
DOI:https://doi.org/10.1093/pnasnexus/pgae252

真の血圧を継続的に測定する初の非侵襲的方法を開発(Caltech Team Develops First Noninvasive Method to Continually Measure True Blood Pressure)

Abstract

Cardiovascular disease is the leading cause of death worldwide. Existing methods for continuous, noninvasive blood pressure (BP) monitoring suffer from poor accuracy, uncomfortable form factors, or a need for frequent calibration, limiting their adoption. We introduce a new framework for continuous BP measurement that is noninvasive and calibration-free called resonance sonomanometry. The method uses ultrasound imaging to measure both the arterial dimensions and artery wall resonances that are induced by acoustic stimulation, which offers a direct measure of BP by a fully determined physical model. The approach and model are validated in vitro using arterial mock-ups and then in multiple arteries in human subjects. This approach offers the promise of robust continuous BP measurements, providing significant benefits for early diagnosis and treatment of cardiovascular disease.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました